1-8 of 8
Amy Guo, PhD
Close
Sort by
Journal Articles

Comparison of Adherence Between Nilotinib and Dasatinib As Second-Line Therapies in Chronic Myeloid Leukemia

Annie Guerin, MSc, Vamsi K Bollu, PhD, MBA, Amy Guo, PhD, Michael Stepner, BA, James D Griffin, MD, Eric Qiong Wu, PhD
Journal: Blood
Blood (2011) 118 (21): 2754.
https://doi.org/10.1182/blood.V118.21.2754.2754
Published: 2011
Journal Articles

The Economic Burden of Pleural Effusions (PE) In Patients with Chronic Myeloid Leukemia (CML).

Eric Qiong Wu, PhD, Annie Guerin, MSc, Vamsi Bollu, PhD, MBA, Denise Williams, MD, Amy Guo, PhD, Diego Ponce de Leon Barido, BA, BS, Andrew Peng Yu, PhD, Alfonso Quintás-Cardama, MD
Journal: Blood
Blood (2010) 116 (21): 3841.
https://doi.org/10.1182/blood.V116.21.3841.3841
Published: 2010
Journal Articles

Comparison of Adherence Between Nilotinib and Dasatinib as Second-Line Therapies In Chronic Myeloid Leukemia.

Annie Guerin, MSc, Vamsi Bollu, PhD, MBA, Amy Guo, PhD, James D. Griffin, MD, Andrew Peng Yu, PhD, Eric Qiong Wu, PhD
Journal: Blood
Blood (2010) 116 (21): 3437.
https://doi.org/10.1182/blood.V116.21.3437.3437
Published: 2010
Journal Articles

Monitoring and Treatment of Transfusional Iron Overload: Findings from an Electronic Medical Records Review Study at the Moffitt Cancer Center and Research Institute.

Leslie A Ray, PharmD, Gene A. Wetzstein, PharmD, BCOP, Si-Tien Wang, MS, Amy Guo, PhD, Caroline Korves, ScD, Bentley Clinton, BA, Robert Wei, BA, Mei S. Duh, ScD, MPH
Journal: Blood
Blood (2010) 116 (21): 1503.
https://doi.org/10.1182/blood.V116.21.1503.1503
Published: 2010
Journal Articles

Comparison of Skeletal Complications and Treatment Patterns Associated with Early Versus Delayed Zoledronic Acid Therapy In Multiple Myeloma

Andrew Peng Yu, PhD, Arielle G Bensimon, BA, Maryna Marynchenko, MBA, Eric Qiong Wu, PhD, Madhav Namjoshi, PhD, Amy Guo, PhD, Solveig G Ericson, MD, PhD, Noopur Raje, MD
Journal: Blood
Blood (2010) 116 (21): 1956.
https://doi.org/10.1182/blood.V116.21.1956.1956
Published: 2010
Journal Articles

Persistence and Compliance of Deferoxamine Versus Deferasirox in Medicaid Patients with Sickle-Cell Disease.

Lanetta B Jordan, MD, MPH, MSPH, Francis Vekeman, MA, Anirban Sengupta, PhD, Mitra Corral, MPH, MS, Amy Guo, PhD, Mei Sheng Duh, MPH, ScD
Journal: Blood
Blood (2009) 114 (22): 1982.
https://doi.org/10.1182/blood.V114.22.1982.1982
Published: 2009
Journal Articles

Non-Adherence to Imatinib in Chronic Myeloid Leukemia Patients Is Associated with a Short Term and Long Term Negative Impact On Healthcare Utilization and Costs.

Eric Qiong Wu, PhD, Vamsi K Bollu, PhD, MBA, Amy Guo, PhD, Annie Guerin, MSc, Andrew Peng Yu, PhD, Andres Sirulnik, MD, PhD, James D Griffin, MD
Journal: Blood
Blood (2009) 114 (22): 4270.
https://doi.org/10.1182/blood.V114.22.4270.4270
Published: 2009
Journal Articles

Comparison of Healthcare Utilization and Costs Between Nilotinib and Dasatinib as Second Line Therapies in Chronic Myeloid Leukemia.

Eric Qiong Wu, PhD, Vamsi K Bollu, PhD, MBA, Amy Guo, PhD, Annie Guerin, MSc, Magda Tsaneva, BA, Denise Williams, MD, James D Griffin, MD
Journal: Blood
Blood (2009) 114 (22): 4286.
https://doi.org/10.1182/blood.V114.22.4286.4286
Published: 2009